Bicara Therapeutics, Inc. (BCAX)
20.06
+0.77
(+3.99%)
USD |
NASDAQ |
May 19, 16:00
20.06
0.00 (0.00%)
After-Hours: 20:00
Bicara Therapeutics EPS Diluted (Quarterly) : -0.9258 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bridgebio Oncology Therapeutics, Inc. | -526.11 |
| Viridian Therapeutics, Inc. | -1.026 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.21M |
| Total Expenses (Quarterly) | 56.21M |
| Enterprise Value | 729.12M |
| Earnings Yield | -13.82% |
| Normalized Earnings Yield | -13.82 |